2 results
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Daliresp (Roflumilast ... GOLD guidelines ... recommendations for the treatment ... won’t have any clinical ... /ambcarerx #Daliresp
COPD Management Algorithm - GOLD 2019 guidelines 

Categorize into COPD GOLD A-D -> Initiate first-line therapy
Algorithm - GOLD ... increases risk of pneumonia ... higher risk of pneumonia ... #Management #Pulmonary ... #Algorithm #pharmacology